本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aspire Biopharma Holdings Inc.

8.27
+0.46005.89%
盤後8.270.00000.00%19:30 EDT
成交量:2.89萬
成交額:24.19萬
市值:1,159.95萬
市盈率:-0.97
高:8.80
開:7.60
低:7.60
收:7.81
52周最高:714.00
52周最低:3.31
股本:140.26萬
流通股本:111.36萬
量比:0.97
換手率:2.59%
股息:- -
股息率:- -
每股收益(TTM):-8.5310
每股收益(LYR):-491.2689
淨資產收益率:-1032.14%
總資產收益率:60.58%
市淨率:0.99
市盈率(LYR):-0.02

資料載入中...

2025/09/26

重要事件披露

Form 8-K - Current report
2025/09/26

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/09/18

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/08/22

重要事件披露

Form 8-K - Current report
2025/08/13

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2025/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/30

重要事件披露

Form 8-K - Current report
2025/06/18

重要事件披露

Form 8-K - Current report
2025/06/10

重要事件披露

Form 8-K - Current report
2025/05/28

SEC問詢函

Form CORRESP - Correspondence
2025/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/04/30

重要事件披露

Form 8-K - Current report
2025/04/19

SEC問詢函

Form CORRESP - Correspondence
2025/04/18

重要事件披露

Form 8-K - Current report
2025/04/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/04/07

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/21

重要事件披露

Form 8-K - Current report
2025/02/20

重要事件披露

Form 8-K - Current report
2025/02/19

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities